Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Drug Alcohol Depend. 2012 Aug 27;128(1-2):161–165. doi: 10.1016/j.drugalcdep.2012.08.003

Table 2.

Correlates of clinically significant pain in past week (N = 480)

Univariate Regression Multivariate Regression

OR (95% CI) P
value*
OR (95% CI) P value*
Age (years)
 ≤ 46 Reference 0.011 Reference 0.427
 > 46 1.59 (1.12-2.28) 1.11 (0.72-1.71)
Marital status
 Married Reference 0.009 Reference 0.646
 Unmarried 0.52 (0.32-0.85) 0.59 (0.33-1.05)
Current use of prescribed
opioid therapy for pain
treatment
 No Reference < 0.001 Reference < 0.001
 Yes 8.77 (5.02-15.31) 7.74 (4.25-14.13)
Current methadone dose
(mg)a
Reference 0.003 Reference 0.027
1.01 (1.00-1.01) 1.01 (1.00-1.01)
Number of medical
comorbiditiesb
Reference < 0.001 Reference < 0.001
2.34 (1.72-3.18) 2.09 (1.45-2.99)
BDI-II
 Minimal/mild Reference < 0.001 Reference 0.010
 Moderate/severe 2.38 (1.66-3.43) 2.25 (1.40-3.62)
MOS-SF-12
 MCS 1.00 (0.99-1.02) 0.950 1.01 (0.99-1.03) 0.330
 PCS 0.96 (0.93-0.98) 0.000 0.97 (0.94-1.00) 0.070

Abbreviations: BDI-II, Beck Depression Inventory-II; MOS-SF-12, Medical Outcomes Survey-Short Form; MCS, Mental Components Summary Score; PCS, Physical Components Summary Score, controlled for bodily pain.

a

OR for each 1 mg increase in methadone dose.

b

OR for each increasing level of comorbidity.

*

p < 0.05